Subscribe
farmer-3
fotografixx / iStockphoto.com
26 July 2018Biotechnology

CJEU tightens gene-editing rules with GMO decision

Genome-editing techniques, including CRISPR/Cas9, will be subject to more stringent regulations after a ruling from Europe’s highest court yesterday.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
CJEU gene-editing decision ‘could stifle’ innovation in Europe
30 July 2018   A ruling handed down last week by the Court of Justice of the European Union could stifle innovation in the gene-editing field, causing Europe to lag behind the rest of the world, commentators say.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Biotechnology
CJEU gene-editing decision ‘could stifle’ innovation in Europe
30 July 2018   A ruling handed down last week by the Court of Justice of the European Union could stifle innovation in the gene-editing field, causing Europe to lag behind the rest of the world, commentators say.

More on this story

Biotechnology
CJEU gene-editing decision ‘could stifle’ innovation in Europe
30 July 2018   A ruling handed down last week by the Court of Justice of the European Union could stifle innovation in the gene-editing field, causing Europe to lag behind the rest of the world, commentators say.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers